Channel profile image
Talks (2017)
REAL WORLD MACRE RISK & JAKi
Jun 13
JAKi and GI perforation
Jun 09
SYL1801 (Sylentis) eye drops for wet AMD
Jun 09
Pistachios for Eye Health
Jun 09
Mirugen's Single-Injection Therapy
Jun 09
Algorithm for guiding therapy
Jun 07
Side effects of Systemic Therapy
Jun 07
Antiviral Therapy in HCC
Jun 07
Hepatic Dysfunction in HCC
Jun 07
HCC Treatment in Advanced Liver disease
Jun 07
ATOMIC trial positive (1/2)
Jun 05
CLINICAL use of PRO's in RHEUM
Jun 04
GLP1 and MASLD
Jun 03
GLP1 RA Gastroparesis
Jun 03
GLP1 Pediatric Atopy
Jun 03
GLP1 and GI side Effects
Jun 03
GLP1 Receptor Agonists - the Discovery
Jun 03
UVEITIS reveiw for RHEUMS
Jun 03
Conversations in BC w/ Dr. Meisel
Jun 02
RARE LUPUS COMPLICATIONS Rx!
Jun 02
Conversations in BC w/ Dr. Gradishar
Jun 02
More on AMD OCT biomarkers
Jun 01
Conversations in BC w/ Dr. Ahmed
May 31
Conversations in BC w/ Dr. Stover
May 31
OS results from BREAKWATER
May 30
Summary of medical retina trials
May 30
AMD and immune mediated diseases
May 29
ctDNA_GC_9
May 29
ctDNA_GC_7
May 29
ctDNA_GC_5
May 29
ctDNA_GC_3
May 28
ctDNA_GC_2
May 28
EOCRC_9
May 28
EOCRC_7
May 28
EOCRC_5
May 28
EOCRC_3
May 28
EOCRC_1
May 28
85 different CAR T cells rx for autoimme
May 27
Microbiome and IBS therapies
May 27
Low FODMAP and microbiome
May 27
Restrictive dietary patterns
May 27
Short chain fatty acids & IBS
May 27
Microbiome in IBS-2
May 27
RifaximinNAC_10
May 26
RifaximinNAC_8
May 26
RifaximinNAC_6
May 26
RifaximinNAC_4
May 26
RifaximinNAC_2
May 26
RifaximinNAC_1
May 26
overall survival from CM577
May 23
Petry on new LUPUS renal guides
May 21
AVTO6 biosimilar
May 21
Stem cells for AMD - Luxa Biotechnology
May 21
Cognition Therapeutics -Oral zervimesine
May 21
OCU410 Gene Therapy (ArMaDa Study)
May 21
LIGHTSITE IIIB (PBM in Dry AMD)
May 21
FDA approval of retifanlimab for anal ca
May 16
tocilizumab in PDAC
May 13
Sarcopenia and Rheumatology
May 12
Summary of ANCA Rx guidelines 2025
May 08
Loading logo